Free Trial

Futura Medical (FUM) Competitors

Futura Medical logo
GBX 12.50 +0.25 (+2.04%)
As of 11:50 AM Eastern

FUM vs. CIR, BVXP, 4BB, TILS, VSN, SCLP, OBI, MPH, HVO, and ORPH

Should you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include Circassia Group (CIR), Bioventix (BVXP), 4basebio (4BB), Tiziana Life Sciences (TILS), Verseon (VSN), Scancell (SCLP), Ondine Biomedical (OBI), Mereo BioPharma Group plc (MPH.L) (MPH), hVIVO (HVO), and Open Orphan (ORPH). These companies are all part of the "biotechnology" industry.

Futura Medical vs. Its Competitors

Circassia Group (LON:CIR) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

35.7% of Futura Medical shares are held by institutional investors. 32.1% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Futura Medical had 1 more articles in the media than Circassia Group. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Circassia Group. Futura Medical's average media sentiment score of 1.11 beat Circassia Group's score of 0.00 indicating that Futura Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Circassia Group Neutral
Futura Medical Positive

Circassia Group has a net margin of 0.00% compared to Futura Medical's net margin of -44.64%. Circassia Group's return on equity of 0.00% beat Futura Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Circassia GroupN/A N/A N/A
Futura Medical -44.64%-56.44%-26.59%

Circassia Group has higher revenue and earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Circassia Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Circassia Group£27.90M0.00N/A£0.01N/A
Futura Medical£8.68M4.49-£3.88M-£1.21-10.31

Summary

Circassia Group beats Futura Medical on 6 of the 10 factors compared between the two stocks.

Get Futura Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FUM vs. The Competition

MetricFutura MedicalBiotechnology IndustryMedical SectorLON Exchange
Market Cap£38.96M£134.48M£5.46B£3.03B
Dividend Yield4.55%3.74%4.71%5.02%
P/E Ratio-10.313.7829.52176.75
Price / Sales4.494,245.36420.58264,367.13
Price / Cash20.4313.1935.8327.97
Price / Book4.8339.388.304.54
Net Income-£3.88M-£90.99M£3.24B£5.90B
7 Day Performance-6.76%-1.65%-3.56%-0.86%
1 Month Performance64.32%11.29%5.91%6.19%
1 Year Performance-65.28%181.26%23.17%65.64%

Futura Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FUM
Futura Medical
N/AGBX 12.50
+2.0%
N/A-63.4%£38.96M£8.68M-10.3112Gap Up
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
BVXP
Bioventix
N/AGBX 2,700
+0.9%
N/A-39.9%£141.38M£13.65M17.4612
4BB
4basebio
N/AGBX 991
+5.3%
GBX 1,600
+61.5%
-34.7%£126.95M£311K-1,270.51101Gap Up
TILS
Tiziana Life Sciences
N/AN/AN/AN/A£113.85M-£3.60M-3.5911
VSN
Verseon
N/AN/AN/AN/A£112.24MN/A-5.17N/AGap Up
SCLP
Scancell
N/AGBX 9.67
-0.8%
N/A-33.4%£100.19MN/A-14.8351News Coverage
OBI
Ondine Biomedical
N/AC$13.25
+3.9%
N/A+64.3%C$95.27MC$48.60K-3.99N/AHigh Trading Volume
MPH
Mereo BioPharma Group plc (MPH.L)
N/AN/AN/AN/A£89.76MN/A-0.2150Gap Down
HVO
hVIVO
2.4974 of 5 stars
GBX 9.93
-3.1%
GBX 28
+181.9%
-66.1%£70.27M£68.74M4.10N/ANews Coverage
Analyst Forecast
ORPH
Open Orphan
N/AN/AN/AN/A£67.09M£34.71M-25.30179News Coverage

Related Companies and Tools


This page (LON:FUM) was last updated on 8/1/2025 by MarketBeat.com Staff
From Our Partners